Ribopeutic
Latest round
- Series A
Last raised
- Mar 2025
Total raised
- Undisclosed
Investors
- 3
About Ribopeutic
Established in 2022 and based in Hangzhou, China, Ribopeutic is a biomedical service provider that provides small molecule drugs targeting RNA. The company's main business is the development of small molecule drugs targeting RNA. The company generates revenue by providing small molecule drugs targeting RNA.
Who invested in Ribopeutic
3 investors across 2 rounds
See all investors in Ribopeutic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ribopeutic
Who invested in Ribopeutic?
Ribopeutic has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ribopeutic raised?
Ribopeutic has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ribopeutic last raise money?
Ribopeutic's most recent round on record is a Series A, in Mar 2025.
What does Ribopeutic do?
Established in 2022 and based in Hangzhou, China, Ribopeutic is a biomedical service provider that provides small molecule drugs targeting RNA.
Where is Ribopeutic headquartered?
Ribopeutic is headquartered in Hangzhou, China.
Which VCs invest in companies like Ribopeutic?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Ribopeutic's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Ribopeutic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.